A new review finds that next-generation BET-targeted therapies, including selective inhibitors and PROTACs, are addressing ...
Scientists at VCU Massey Comprehensive Cancer Center have developed an autophagy-targeting chimera that redirects cancer ...
As therapeutic antibodies become more complex, where is the field making real progress and which problems are proving hardest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results